Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Flow cytometry-based immunophenotypic analysis of primary systemic light chain amyloidosis.

Diao X, Li J, Ouyang J, Liu J, Huang B, Chen M, Gu J.

Oncol Lett. 2017 Apr;13(4):2691-2697. doi: 10.3892/ol.2017.5767. Epub 2017 Feb 22.

2.

The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patients.

Ceran F, Falay M, Dağdaş S, Özet G.

Turk J Haematol. 2017 Aug 2;34(3):226-232. doi: 10.4274/tjh.2016.0394. Epub 2017 Mar 8.

3.
4.

CD56 Expression in Odontogenic Cysts and Tumors.

Jaafari-Ashkavandi Z, Dehghani-Nazhvani A, Razmjouyi F.

J Dent Res Dent Clin Dent Prospects. 2014 Fall;8(4):240-5. doi: 10.5681/joddd.2014.043. Epub 2014 Dec 3.

5.

Extramedullary plasmacytoma of the trachea.

Sukumaran R, Nair RA, Jacob PM, Koshy SM, Mathew AP.

Head Neck Pathol. 2014 Jun;8(2):220-4. doi: 10.1007/s12105-013-0491-7. Epub 2013 Sep 18.

6.

Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions.

Danylesko I, Beider K, Shimoni A, Nagler A.

Clin Dev Immunol. 2012;2012:753407. doi: 10.1155/2012/753407. Epub 2012 May 10. Review.

7.

EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.

van Dongen JJ, Lhermitte L, Böttcher S, Almeida J, van der Velden VH, Flores-Montero J, Rawstron A, Asnafi V, Lécrevisse Q, Lucio P, Mejstrikova E, Szczepański T, Kalina T, de Tute R, Brüggemann M, Sedek L, Cullen M, Langerak AW, Mendonça A, Macintyre E, Martin-Ayuso M, Hrusak O, Vidriales MB, Orfao A; EuroFlow Consortium (EU-FP6, LSHB-CT-2006-018708).

Leukemia. 2012 Sep;26(9):1908-75. doi: 10.1038/leu.2012.120. Epub 2012 May 3.

8.

Neural cell adhesion molecule potentiates the growth of murine melanoma via β-catenin signaling by association with fibroblast growth factor receptor and glycogen synthase kinase-3β.

Liu R, Shi Y, Yang HJ, Wang L, Zhang S, Xia YY, Wong JL, Feng ZW.

J Biol Chem. 2011 Jul 22;286(29):26127-37. doi: 10.1074/jbc.M111.237297. Epub 2011 May 31.

9.

Antibody-maytansinoid conjugates for the treatment of myeloma.

Lutz RJ, Whiteman KR.

MAbs. 2009 Nov-Dec;1(6):548-51. Epub 2009 Nov 9. Review.

10.

Extramedullary plasmocytoma associated with a massive deposit of amyloid in the duodenum.

Carneiro FP, Sobreira MN, Maia LB, Sartorelli AC, Franceschi LE, Brandão MB, Calaça BW, Lustosa FS, Lopes JV.

World J Gastroenterol. 2009 Jul 28;15(28):3565-8.

11.

Specific detection of CD56 (NCAM) isoforms for the identification of aggressive malignant neoplasms with progressive development.

Gattenlöhner S, Stühmer T, Leich E, Reinhard M, Etschmann B, Völker HU, Rosenwald A, Serfling E, Bargou RC, Ertl G, Einsele H, Müller-Hermelink HK.

Am J Pathol. 2009 Apr;174(4):1160-71. doi: 10.2353/ajpath.2009.080647. Epub 2009 Feb 26.

12.

Immunophenotypic studies of monoclonal gammopathy of undetermined significance.

Olteanu H, Wang HY, Chen W, McKenna RW, Karandikar NJ.

BMC Clin Pathol. 2008 Nov 28;8:13. doi: 10.1186/1472-6890-8-13.

Supplemental Content

Support Center